SIRT1 and Hyperglycemia: Resveratrol has been shown to suppress the pro-atherosclerotic effects of hyperglycemia on ECs by limiting ET-1 and E-selectin mRNA expression and boosting endothelial NO synthase via eNOS/NO signaling, which is triggered by SIRT1 activation [129].